Oxford’s PepGen Launches Into DMD With Next-Gen Oligonucleotide Platform

Aims To Challenge Sarepta

 
• By Andrew McConaghie
  
Caroline Godfrey
PepGen's chief executive Caroline Godfrey.

More from Business

More from Scrip